03 Nov 2025
2 mins
MHRA enforcement action on unlicensed weight-loss injections
UK medicines regulator, the MHRA, has carried out an extensive, two-day raid on an illicit weight loss medicines facility.
More
Life sciences blog
Our life sciences law blog brings you up to date news and views on legal, regulation and policy decisions affecting the life science sector.
Results: 167 items
16 Oct 2025
1 mins
Precision bred varieties: What’s changing for plant breeders?
Legislation passed in 2023 opened the door to greater flexibility for precision genetic technology. From November 2025, new rules will streamline the approval process (in England only) for precision bred plant varieties—those developed using advanced gene editing tools like CRISPR, but without introducing foreign DNA.
More
15 Oct 2025
7 mins
PISCES: A new private stock market – implications for life sciences companies
PISCES is a new type of platform where shares in private companies can be traded. As companies choose to stay private for longer, PISCES should give investors the opportunity to trade private company shares easily and efficiently in an organised marketplace.
More
14 Oct 2025
3 mins
Preparing for reform: Updated clinical trials guidance ahead of 2026 changes
The UK’s clinical trials framework is undergoing a major transformation. Both the Medicines and Healthcare products Regulatory Agency (MHRA) and the Health Research Authority (HRA) have published updated guidance to support sponsors and other stakeholders through the transition.
More
03 Oct 2025
2 mins
European competition authority carries out dawn raids in the vaccines sector
The European Commission announced on 30 September that it has carried out unannounced inspections (otherwise known as ‘dawn raids’) at the premises of a company active in the vaccines sector. The dawn raids constitute a preliminary step in the Commission’s investigation into whether the inspected company has undertaken practices which may amount to anticompetitive disparagement.
More
22 Aug 2025
2 mins
Fast track clinical trial approvals becoming a reality
The UK is positioning itself as a leading choice for clinical research. Alongside streamlining its legislative framework to offer greater efficiency, accessibility and innovation, the UK government is pushing for improvements to contracting and review processes.
More
04 Aug 2025
4 mins
AI as a medical device and navigating compliance to work with the NHS
The UK government is promoting innovative technology to improve patient care. This blog explores current regulatory requirements for developers and offers guidance on working with the NHS during the development process.
More
11 Jul 2025
3 mins
Understanding borderline products – Food supplements and other consumer products, advertising rules
In our recent webinar, we explored the complexities of borderline products, focusing on categories that often raise challenging questions.
More
10 Jul 2025
3 mins
Understanding borderline products – medicines, drug/device combination products, engineered tissues and cells
Our Life Sciences Legal Forum offers quarterly sessions focusing on hot topics within the life sciences sector.
More
09 Jul 2025
3 mins
Understanding borderline products - medical devices, MedTech and health apps
Our Life Sciences Legal Forum offers a series of quarterly sessions focusing on hot topics within the life sciences sector. In a recent webinar, we explored the complexities of borderline products, focusing on categories that often raise challenging questions.
More
08 Jul 2025
7 mins
Navigating Trends in Life Sciences Fundraising and Corporate Transactions
Our Life Sciences Legal Forum offers a series of quarterly sessions focusing on hot topics within the life sciences sector. In a recent webinar, we took a step back to consider trends and challenges in life sciences fundraising and corporate transactions
More
20 Jun 2025
3 mins
Safe and Ethical Inclusion of Pregnant and Breastfeeding Women in Clinical Trials: a New ICH Guideline and a WHO Task Force
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) has released a draft guideline, ICH E21 (available here), focusing on the inclusion of pregnant and breastfeeding women in clinical trials.
More